ERIN MURPHY: Open Payments
NPI 1760541122 · STONEHAM, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,140 in 19 payments from 10 companies in 2025. Trend: 2023 $222 · 2024 $287 · 2025 $2,140
Travel & lodging: $1,204Food & beverage: $886Long term medical supply or device loan: $50
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 7 | $1,541 |
| BETA BIONICS, INC. | 2 | $157 |
| Insulet Corporation | 1 | $121 |
| CeQur Corporation | 1 | $117 |
| Lilly USA, LLC | 3 | $71 |
| Abbott Laboratories | 1 | $50 |
| Madrigal Pharmaceuticals | 1 | $27 |
| Novo Nordisk Inc | 1 | $19 |
| Tandem Diabetes Care, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $17 |
Products named: MINIMED 780G, iLet Bionic Pancreas, OMNIPOD, CeQur Simplicity, MOUNJARO, FREESTYLE INSULINX, REZDIFFRA, Ozempic.
Industry payments across MA — which companies pay providers there.
